28
Oct
2025

Polpharma Biologics S.A.

Exhibitor at CPHI Frankfurt 2025 stand 4.1M64, Bioproduction
About Us

Polpharma Biologics is an international biotechnology company with integrated operations in the European Union (EU), developing and manufacturing biosimilar medicines. Using patented solutions and state-of-the-art platform technologies, we develop biosimilar products to treat a range of conditions in major therapeutic areas. 

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • PL
  • 2021
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
Generics/Biosimilars Manufacturer
Primary activities
Biopharmaceutical
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 4.1M64, Bioproduction

Products Featured at CPHI Frankfurt 2025

  • Pipeline

    Product Pipeline

    Polpharma Biologics has its own pipeline of biosimilars for out-licensing.
    We are focused on advancing and expanding our product portfolio to increase patient access to these much-needed therapies and are open to partnering with other organizations to co-develop or commercialize our biosimilars.